Central Nervous System Metastases in Lung Cancer Patients: From Prevention to Diagnosis and Treatment
Approximately 40% of lung cancer patients will develop central nervous system (CNS) metastases during the course of their disease. Most of these are brain metastases, but up to 10% will develop leptomeningeal metastases. Known risk factors for CNS metastases development are small cell lung cancer (S...
Saved in:
Main Author: | Deepa S. Subramaniam (auth) |
---|---|
Other Authors: | Lizza E.L. Hendriks (auth), Anne-Marie C. Dingemans (auth) |
Format: | Book Chapter |
Published: |
Frontiers Media SA
2019
|
Subjects: | |
Online Access: | Get Fullteks DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanisms and Therapy for Cancer Metastasis to the Central Nervous System
Published: (2019) -
Clinical Application of Stereotactic Body Radiotherapy (SBRT): Cranium to Prostate
by: Dwight E. Heron
Published: (2016) -
The Role of Modern Neuro-oncology in the Treatment of Primary CNS Tumors, and Brain and Spinal Metastases
Published: (2020) -
Cancer and Bone Metastasis
Published: (2020) -
Contemporary Management of Intracranial Metastatic Disease
Published: (2019)